-
Get Involved
Diversifying DonorsA diverse donor pool benefits patients in need of bone marrow transplants.
by Lindsey Konkel
-
Survivor Profile
Reasons to DreamDespite a metastatic lung cancer diagnosis, Emily Bennett Taylor was able to look beyond the illness in 2012 to her dream of raising a family. Today, with no evidence of disease, she is the mother of two baby girls.
by Marci A. Landsmann
-
Q&A
A Rare DriveChordoma survivor Josh Sommer brings together researchers and patients to develop better treatments for an uncommon cancer.
by Kate Yandell
-
From the Editor-in-Chief
Can Big Data Launch Cancer Research?Analysis of big data in cancer medicine will be key to delivering on the cancer moonshot.
by William G. Nelson, MD, PhD
-
Forward Look
Cancer Centers Unite to Increase HPV Vaccination RatesJoint statement recommends girls and boys be vaccinated before age 13.
by Cameron Walker
-
Forward Look
Vice President Joe Biden Brings “Moonshot” to AACR Annual MeetingVice President Joe Biden is leading a new, national $1 billion Moonshot initiative to propel cancer research. Speaking in April at the American Association for Cancer Research (AACR) Annual Meeting 2016 in New Orleans, Biden emphasized the need for scientists to collaborate to move cancer research forward. “There is more brainpower in this room than exists […]
by Sue Rochman
-
Survivor Profile
In Support and ServiceRetired Army colonel and prostate cancer survivor Jim Williams asks men to pay better attention to their health.
by Lauren Gravitz
-
-
Biden Calls for CollaborationVice president cites immunotherapy, big data and team science as innovative ways to speed progress against cancer.
by Kevin McLaughlin
-
From the Editor-in-Chief
Cancer Research: Back to the BasicsMore basic research is needed to understand how various alterations in genes lead to cancers.
by William G. Nelson, MD, PhD
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
